Public Employees Retirement System of Ohio Acquires 8,533 Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH)

Public Employees Retirement System of Ohio lifted its stake in Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 10.3% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 91,779 shares of the company's stock after purchasing an additional 8,533 shares during the period. Public Employees Retirement System of Ohio owned 0.19% of Prestige Consumer Healthcare worth $6,617,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently modified their holdings of PBH. Ariel Investments LLC raised its stake in Prestige Consumer Healthcare by 10.7% during the 2nd quarter. Ariel Investments LLC now owns 2,835,203 shares of the company's stock worth $195,204,000 after acquiring an additional 274,212 shares during the period. Victory Capital Management Inc. increased its stake in shares of Prestige Consumer Healthcare by 9.0% in the second quarter. Victory Capital Management Inc. now owns 2,074,460 shares of the company's stock worth $142,827,000 after purchasing an additional 171,357 shares in the last quarter. Allspring Global Investments Holdings LLC raised its position in shares of Prestige Consumer Healthcare by 19.3% during the 3rd quarter. Allspring Global Investments Holdings LLC now owns 1,575,170 shares of the company's stock valued at $113,570,000 after purchasing an additional 255,045 shares during the period. Congress Asset Management Co. lifted its stake in shares of Prestige Consumer Healthcare by 7.8% during the 3rd quarter. Congress Asset Management Co. now owns 865,123 shares of the company's stock valued at $62,375,000 after buying an additional 62,411 shares in the last quarter. Finally, Boston Trust Walden Corp bought a new position in Prestige Consumer Healthcare in the 3rd quarter worth $41,785,000. 99.95% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at Prestige Consumer Healthcare

In other news, CEO Ronald M. Lombardi sold 10,875 shares of the business's stock in a transaction that occurred on Tuesday, November 19th. The stock was sold at an average price of $82.60, for a total transaction of $898,275.00. Following the transaction, the chief executive officer now owns 320,952 shares of the company's stock, valued at approximately $26,510,635.20. The trade was a 3.28 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, SVP Mary Beth Fritz sold 9,885 shares of the stock in a transaction on Tuesday, November 12th. The shares were sold at an average price of $81.97, for a total value of $810,273.45. Following the sale, the senior vice president now owns 18,835 shares in the company, valued at $1,543,904.95. The trade was a 34.42 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 38,810 shares of company stock worth $3,187,300 in the last three months. Insiders own 1.60% of the company's stock.

Prestige Consumer Healthcare Price Performance

Shares of PBH stock traded down $1.28 during trading hours on Friday, hitting $82.30. The stock had a trading volume of 241,429 shares, compared to its average volume of 251,842. The company has a debt-to-equity ratio of 0.61, a current ratio of 3.56 and a quick ratio of 2.10. The stock has a market capitalization of $4.07 billion, a price-to-earnings ratio of 20.02, a PEG ratio of 2.35 and a beta of 0.49. Prestige Consumer Healthcare Inc. has a one year low of $57.95 and a one year high of $86.36. The stock's 50-day moving average price is $78.12 and its two-hundred day moving average price is $72.47.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last released its quarterly earnings data on Thursday, November 7th. The company reported $1.09 earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of $1.09. Prestige Consumer Healthcare had a return on equity of 12.23% and a net margin of 18.54%. The business had revenue of $283.79 million for the quarter, compared to the consensus estimate of $282.09 million. During the same quarter in the previous year, the company posted $1.07 EPS. The company's revenue was down .9% compared to the same quarter last year. Equities analysts forecast that Prestige Consumer Healthcare Inc. will post 4.44 EPS for the current year.

Analyst Ratings Changes

A number of equities research analysts have commented on the company. DA Davidson reissued a "buy" rating and set a $95.00 price target on shares of Prestige Consumer Healthcare in a report on Monday, November 11th. StockNews.com cut Prestige Consumer Healthcare from a "buy" rating to a "hold" rating in a research report on Tuesday. Jefferies Financial Group reissued a "hold" rating and issued a $76.00 price target (up from $70.00) on shares of Prestige Consumer Healthcare in a report on Tuesday, September 24th. Finally, Sidoti lowered shares of Prestige Consumer Healthcare from a "buy" rating to a "neutral" rating and set a $90.00 price objective for the company. in a report on Monday, December 9th. Three research analysts have rated the stock with a hold rating and two have issued a buy rating to the company. According to data from MarketBeat, Prestige Consumer Healthcare has an average rating of "Hold" and an average target price of $85.25.

Prestige Consumer Healthcare Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.